Primera bipartición del tránsito intestinal en el Instituto Mexicano del Seguro Social First intestinal transit bipartition at the Mexican Institute for Social Security
Main Article Content
Keywords
Bariatric Surgery, Obesity, Morbid, Weight Loss, Diabetes Mellitus
Abstract
Abstract
Background: Obesity is a highly prevalent disease that significantly impacts quality of life and life expectancy. Over the past decades, bariatric surgery has become the gold standard for treating obesity and its comorbidities. In 2006, Santoro et al. described the technique of intestinal transit bipartition (ITB) to enhance neuroendocrine mechanisms of weight loss while minimizing nutritional deficiencies common in other procedures. The objective was to describe the first case of ITB performed in a high specialty center as a surgical treatment for obesity.
Clinical case: A 44-year-old male patient with grade III obesity and comorbidities, including type 2 diabetes mellitus and obstructive sleep apnea. The patient underwent ITB combined with sleeve gastrectomy. During follow-up, a significant reduction in body weight was observed (%EWL of 94.9% at 6 months), without alterations in biochemical parameters such as albumin, hemoglobin, or vitamin D levels. The procedure was safe, with no surgical or postoperative complications.
Conclusion: ITB is a promising surgical technique for the treatment of obesity and its comorbidities, with results comparable to other bariatric procedures. Its neuroendocrine effect favors metabolic control and significant weight loss, while limiting nutritional complications. Initial results highlight its safety and feasibility as a therapeutic alternative, although long-term studies are required to confirm its sustained impact on metabolic health.
References
1. Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol. 2021;12:706978. doi: 10.3389/fendo.2021.706978
2. Campos-Nonato I, Galván-Valencia Ó, Hernández-Barrera L, et al. Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex. 2023;65:s238-47. doi: 10.21149/14809
3. Anwar A, Anwar M, Khan D, et al. Assessing the Long-Term Outcomes of Bariatric Surgery on Metabolic Syndrome and Cardiovascular Health. IRABCS. 2024;2(2):211-7. doi: 10.62497/IRABCS.2024.60
4. Wiebe N, Tonelli M. Long-term clinical outcomes of bariatric surgery in adults with severe obesity: A population-based retrospective cohort study. PLoS ONE. 2024;19(6):e0298402. doi: 10.1371/journal.pone.0298402
5. Santoro S, Malzoni C, Velhote M, et al. Digestive Adaptation with Intestinal Reserve: A Neuroendocrine-Based Operation for Morbid Obesity. Obes Surg. 2006;16(10):1371-1379. doi: 10.1381/096089206778663841
6. Santoro S, Castro LC, Velhote MCP, et al. Sleeve Gastrectomy With Transit Bipartition: A Potent Intervention for Metabolic Syndrome and Obesity. Annals of Surgery. 2012;256(1):104-10. doi: 10.1097/SLA.0b013e31825370c0
7. Bhandari M, Fobi MAL, Buchwald JN. Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg. 2019;29(S4):309-45. doi: 10.1007/s11695-019-04032-x
8. Calisir A, Ece I, Yilmaz H, et al. The Mid-Term Effects of Transit Bipartition with Sleeve Gastrectomy on Glycemic Control, Weight Loss, and Nutritional Status in Patients with Type 2 Diabetes Mellitus: a Retrospective Analysis of a 3-Year Follow-up. Obes Surg. 2021;31(11):4724-33. doi: 10.1007/s11695-021-05536-1
9. Al M, Taskin HE. Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes. Surg Endosc. 2022;36(4):2631-42. doi: 10.1007/s00464-021-08769-4
10. Hage K, Ikemiya K, Ghusn W, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass: a multicentered experience with long-term follow-up. Surgery for Obesity and Related Diseases. 2023;19(12):1339-45. doi: 10.1016/j.soard.2023.09.025
11. Hage K, Abi Mosleh K, Sample JW, et al. Preoperative duration of type 2 diabetes mellitus and remission after Roux-en-Y gastric bypass: a single center long-term cohort study. International Journal of Surgery. 2024;110(10):6214-21. doi: 10.1097/JS9.0000000000001139
12. Salazar-Rios E, Martínez Ortíz CA, Salazar-Rios ME, et al. Preoperative risk factors for suboptimal initial clinical response or weight regain in patients undergoing bariatric surgery, a retrospective cohort study from a high-volume center. Langenbeck’s archives of surgery. 2025;410(1):136. doi: 10.1007/s00423-025-03700-0
13. Vieira De Sousa JP, Santos-Sousa H, Vieira S, et al. Assessing Nutritional Deficiencies in Bariatric Surgery Patients: A Comparative Study of Roux-en-Y Gastric Bypass versus Sleeve Gastrectomy. JPM. 2024;14(6):650. doi: 10.3390/jpm14060650
14. Moize V, Laferrère B, Shapses S. Nutritional Challenges and Treatment After Bariatric Surgery. Annual Review of Nutrition. 2024;44(1):289-312. doi: 10.1146/annurev-nutr-061121-101547
15. Holst JJ, Madsbad S, Bojsen-Møller KN, et al. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. Surgery For Obesity and Related Diseases. 2018;14(5):708-14. doi: 10.1016/j.soard.2018.03.003
16. Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: Gastric bipartition, a novel metabolic surgery procedure: A retrospective cohort study. Int J Surg. 2016;34:28-34. doi: 10.1016/j.ijsu.2016.08.018
17. Zhao S, Li R, Zhou J, et al. Sleeve gastrectomy with transit bipartition: a review of the literature. Expert Review of Gastroenterology & Hepatology. 2023;17(5):451-9. doi: 10.1080/17474124.2023.2206563
18. Widjaja J, Yang J, Dong W, et al. Single-Port One Anastomosis Sleeve Gastrectomy with Transit Bipartition: Initial Experience and Technique. Obes Surg. 2024;34(7):2739-43. doi: 10.1007/s11695-024-07295-1
19. Taskin HE, Al M. Longitudinal Outcomes Through 4 Years After Sleeve Gastrectomy with Transit Bipartition. Bariatric Surgical Practice and Patient Care. 2022;17(4):225-36. doi: 10.1089/bari.2021.0082
20. Azevedo FR, Santoro S, Correa-Giannella ML, et al. A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition. Obes Surg. 2018;28(10):3012-9. doi: 10.1007/s11695-018-3239-3
21. Ece I, Yilmaz H, Yormaz S, et al. The Short-Term Effects of Transit Bipartition with Sleeve Gastrectomy and Distal-Roux-en-Y Gastric Bypass on Glycemic Control, Weight Loss, and Nutritional Status in Morbidly Obese and Type 2 Diabetes Mellitus Patients. Obes Surg. 2021;31(5):2062-2071. doi: 10.1007/s11695-020-05212-w
22. Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surgery for Obesity and Related Diseases. 2020;16(4):497-502. doi: 10.1016/j.soard.2019.12.019
23. Demir C, Arslan E, Sariyildiz G, et al. Laparoscopic Sleeve Gastrectomy with Transit Loop Bipartition and Transit Bipartition in Type 2 Diabetic Patients with Obesity: A Retrospective Analysis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 2023;33(4):357-64. doi: 10.1097/SLE.0000000000001189
24. Reiser M, Christogianni V, Nehls F, et al. Short-term Results of Transit Bipartition to Promote Weight Loss After Laparoscopic Sleeve Gastrectomy. Annals of Surgery Open. 2021;2(4):e102. doi: 10.1097/AS9.0000000000000102
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.